Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Endostar pumping into vein with
Gemcitabine-Cisplatin are more effective than Endostar with Gemcitabine-Cisplatin regularly
in the treatment of Non-Small Cell Lung Cancer (NSCLC).